Nicholas B Argento
Overview
Explore the profile of Nicholas B Argento including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hessler D, Fisher L, Guzman S, Strycker L, Polonsky W, Ahmann A, et al.
Diabetes Care
. 2024 May;
47(8):1370-1378.
PMID: 38809903
Objective: To compare the effectiveness of three interventions to reduce diabetes distress (DD) and improve HbA1c among adults with type 1 diabetes (T1D). Research Design And Methods: Individuals with T1D...
2.
Levy C, Galindo R, Parkin C, Gillis J, Argento N
J Diabetes Sci Technol
. 2023 Mar;
18(5):1198-1207.
PMID: 36919680
Gestational diabetes mellitus (GDM) is a common metabolic disease of pregnancy that threatens the health of several million women and their offspring. The highest prevalence of GDM is seen in...
3.
4.
Argento N, Liu J, Hughes A, McAuliffe-Fogarty A
J Diabetes Sci Technol
. 2019 Apr;
14(2):257-261.
PMID: 30931609
Background: The Centers for Medicare and Medicaid Services (CMS) has numerous requirements for coverage of continuous subcutaneous insulin infusion (CSII; insulin pump). Due to recent improvements in diabetes treatment, people...
5.
Edelman S, Argento N, Pettus J, Hirsch I
Diabetes Care
. 2018 Oct;
41(11):2265-2274.
PMID: 30348844
Two types of continuous glucose monitoring (CGM) systems are now available: real-time CGM (rtCGM) and intermittently scanned (isCGM). Current rtCGM systems automatically transmit a continuous stream of glucose data to...
6.
Argento N
Endocr Pract
. 2018 Jul;
24(10):928-931.
PMID: 30035623
CGM = continuous glucose monitor; FDA = U.S. Food and Drug Administration; iCGM = intermittently scanned CGM; MBG = mean blood glucose; rtCGM = real-time CGM; T1D = type 1...
7.
Forlenza G, Argento N, Laffel L
Diabetes Technol Ther
. 2017 Jun;
19(S3):S13-S20.
PMID: 28585878
Clinical use of continuous glucose monitoring (CGM) devices has grown over the past 15 years from a niche concept to becoming standard of care for patients with type 1 diabetes...
8.
Argento N, Nakamura K
Endocr Pract
. 2015 Nov;
22(3):315-22.
PMID: 26523624
Objective: Limited information is available on chronic use of sodium glucose cotransporter 2 inhibitors in type 1 diabetes (T1D). We conducted a retrospective review of T1D patients on Dexcom G4Platinum...
9.
Argento N, Nakamura K
Endocr Pract
. 2014 Aug;
20(12):1297-302.
PMID: 25100367
Objective: Little information is available on personal real-time continuous glucose monitoring (PCGM) in patients ≥65 years old. We report on PCGM use in insulin-requiring patients ≥65 years old in a...
10.
Argento N, Nakamura K, Sala R, Simpson P
Endocr Pract
. 2013 Nov;
20(3):252-60.
PMID: 24246336
Objective: Determine the relationship between mean glucose (MG), as assessed by continuous glucose monitoring (CGM), and hemoglobin A1c (A1C) in insulin-requiring adults in a clinical practice setting and examine the...